Microbot Medical ( (MBOT) ) just unveiled an update.
On February 4, 2025, Microbot Medical announced that its late-breaking abstract on the LIBERTY® Endovascular Robotic System has been accepted for presentation at the Society of Interventional Radiology’s annual meeting in Nashville. This marks the first presentation of data from the ACCESS-PVI trial, highlighting the system’s performance in peripheral vascular interventions, which could significantly impact the company’s market positioning and appeal to potential users among conference attendees.
More about Microbot Medical
Microbot Medical Inc. is a pre-commercial stage medical technology company focused on improving patient care globally. They have developed the world’s first single-use, fully disposable endovascular robotic system, aiming to remove barriers to accessing advanced robotic systems.
YTD Price Performance: 61.40%
Average Trading Volume: 2,974,809
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $51.58M
Find detailed analytics on MBOT stock on TipRanks’ Stock Analysis page.